Molecular epidemiology of staphylococcus aureus strains isolated from inpatients with infected diabetic foot ulcers in an Algerian University Hospital

Clinical Microbiology and Infection

Volumn 19, Issue 9, 2013, Pages

  Djahmi, N ^a,b   Messad, N ^a   Nedjai, S ^b   Moussaoui, A ^b   Mazouz, D ^b   Richard, J L ^c   Sotto, A ^a,d   Lavigne, J P ^a,d  

^a UNIV MONTPELLIER   (France)

^b Centre Hospitalier Universitaire de Annaba   (Algeria)

^c NÎMES UNIVERSITY HOSPITAL   (France)

^d DEPARTMENT OF NEUROLOGY   (France)

Author keywords

Algeria; Diabetic foot ulcer; Ecology; Infection; Multidrug resistant organism; Oligonucleotide array; Staphylococcus aureus

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; COTRIMOXAZOLE; FOSFOMYCIN; PRISTINAMYCIN; TETRACYCLINE;

ACINETOBACTER BAUMANNII; ADULT; ALGERIA; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CITROBACTER; COAGULASE NEGATIVE STAPHYLOCOCCUS; DEBRIDEMENT; DIABETIC FOOT; DNA MICROARRAY; ECOLOGY; ESCHERICHIA COLI; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; IN VITRO STUDY; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MORGANELLA MORGANII; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEUS MIRABILIS; PROTEUS VULGARIS; PROVIDENCIA STUARTII; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; UNIVERSITY HOSPITAL;

BACILLI (CLASS); ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEGIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 84882616824     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12199     Document Type: Article

References (32)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2009; 87: 4-14.
2. National Institute of Public Health: Democratic and Popular Republic of Algeria. Project TAHINA (Epidemiological transition and health impact in North Africa). National Health Survey 2005 (Contract N°IC A3-CT-2002-10011). http://www.ands.dz/insp/Doc_ENS_07_Resume_final_tahina.pdf.
3. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet 2005; 336: 1719-1724.
4. Lipsky BA, Peters EJG, Senneville E et al. Expert opinion on the management of infections in the diabetic foot. Diabetes Metab Res Rev 2012; 28: 163-178.
5. Game F, Jeffcoate W. MRSA and osteomyelitis of the foot in diabetes. Diabet Med 2004; 21: 16-19.
6. Tentolouris N, Petrikkos G, Vallianou N et al. Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect 2006; 12: 186-189.
7. Tentolouris N, Jude E, Smirnof I, Knowles E, Boulton AJM. Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med 1999; 16: 767-771.
8. Dang CN, Prasad YD, Boulton AJM, Jude E. Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med 2003; 20: 159-161.
9. Mantey I, Hill RL, Foster AV, Wilson S, Wade JJ, Edmonds ME. Infection of foot ulcers with Staphylococcus aureus associated with increased mortality in diabetic patients. Commun Dis Public Health 2000; 3: 288-290.
10. Wagner A, Reike H, Angelkort B. Highly resistant pathogens in patients with diabetic foot syndrome with special reference to methicillin-resistant Staphylococcus aureus infection. Dtsch Med Wochenschr 2001; 126: 1353-1356.
11. Antri K, Rouzic N, Dauwalder O et al. High prevalence of methicillin-resistant Staphylococcus aureus clone ST80-IV in hospital and community settings in Algiers. Clin Microbiol Infect 2011; 17: 526-532.
12. Ouchenane Z, Smati F, Rolain JM, Raoult D. Molecular characterization of methicillin-resistant Staphylococcus aureus isolates in Algeria. Pathol Biol 2011; 59: e129-132.
13. Monecke S, Jatzwauk L, Weber S, Slickers P, Ehricht R. DNA microarray based genotyping of MRSA strains from Eastern Saxony. Clin Microbiol Infect 2008; 14: 534-545.
14. Monecke S, Coombs G, Shore AC et al. A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS ONE 2011; 6: e17936.
15. Richard JL, Lavigne JP, Got I et al. Management of patients hospitalized for diabetic foot infection: results of the French OPIDIA study. Diabetes Metab 2011; 37: 208-215.
16. Ge Y, MacDonald D, Hait H, Lipsky B, Zasloff M, Holroyd K. Microbiological profile of infected diabetic foot ulcers. Diabet Med 2002; 19: 1032-1034.
17. Citron D, Goldstein E, Merriam C, Lipsky B, Abramson M. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol 2007; 45: 2819-2828.
18. Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care 2006; 29: 1727-1732.
19. Ramakant P, Verma AK, Misra R et al. Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? Diabetologia 2011; 54: 58-64.
20. Bansal E, Garg A, Bhatia S, Attri AK, Chander J. Spectrum of microbial flora in diabetic foot ulcers. Indian J Pathol Microbiol 2008; 51: 204-208.
21. Vardakas KZ, Horianopoulou M, Falagas ME. Factors associated with treatment failure in patients with diabetic foot infections: an analysis of data from randomized controlled trials. Diabetes Res Clin Pract 2008; 80: 344-351.
22. Shao-Hua W, Zi-Lin S, Yi-Jing G et al. Meticillin-resistant Staphylococcus aureus isolated from foot ulcers in diabetic patients in a Chinese care hospital: risk factors for infection and prevalence. J Med Microbiol 2010; 59: 1219-1224.
23. Mendes JJ, Marques-Costa A, Vilela C et al. Clinical and bacteriological survey of diabetic foot infections in Lisbon. Diabetes Res Clin Pract 2012; 95: 153-161.
24. Eleftheriadou I, Tentolouris N, Argiana V, Jude E, Boulton AJ. Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs 2010; 70: 1785-1797.
25. Harris SR, Feil EJ, Holden MT et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 2010; 327: 469-474.
26. Deurenberg RH, Vink C, Kalenic S, Friedrich AW, Bruggeman CA, Stobberingh EE. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2007; 13: 222-235.
27. Breurec S, Fall C, Pouillot R et al. Epidemiology of methicillin-resistant Staphylococcus aureus lineages in five major African towns: emergence and spread of atypical clones. Clin Microbiol Infect 2011; 17: 160-165.
28. Dufour P, Gillet Y, Bes M et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002; 35: 819-824.
29. Sotto A, Richard JL, Messad N et al. Distinguishing colonization from infection with Staphylococcus aureus in diabetic foot ulcers with miniaturized oligonucleotide arrays: a French multicenter study. Diabetes Care 2012; 35: 617-623.
30. Tristan A, Bes M, Meugnier H et al. Global distribution of Panton-Valentine leukocidine positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 2007; 13: 594-600.
31. Ben Nejma M, Mastouri M, Bel Hadj Jrad B, Nour M. Characterization of ST80 Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus clone in Tunisia. Diagn Microbiol Infect Dis 2008. [Epub ahead of print].
32. Sotto A, Richard JL, Combescure C et al. Beneficial effects of implementing guidelines on microbiology and costs of infected diabetic foot ulcers. Diabetologia 2010; 53: 2249-2255.